| 发明名称 |
NOVEL CRYSTALLINE COMPOUND |
| 摘要 |
This invention relates to a novel amorphous and crystallline forms of 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt, useful as inhibitors of protein kinases, and to their methods of preparation.
|
| 申请公布号 |
WO03048162(A1) |
申请公布日期 |
2003.06.12 |
| 申请号 |
WO2002IB04948 |
申请日期 |
2002.11.25 |
| 申请人 |
PFIZER PRODUCTS INC.;FLANAGAN, MARK, EDWARD;LI, ZHENG, JANE |
发明人 |
FLANAGAN, MARK, EDWARD;LI, ZHENG, JANE |
| 分类号 |
A61K31/519;A61K45/00;A61P1/04;A61P3/10;A61P11/06;A61P17/00;A61P17/06;A61P19/02;A61P25/00;A61P25/28;A61P29/00;A61P35/00;A61P35/02;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07D487/04;(IPC1-7):C07D487/04 |
主分类号 |
A61K31/519 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
